SCHEMBL14214501

SCHEMBL14214501

CC(CCn1cnc2ccccc21)C(C)(C)C

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.62
LMNA P02545 7/20 0.53
SMN1; SMN2 Q16637 6/20 0.53
HTT P42858 5/20 0.53
TSHR P16473 2/20 0.51
NPSR1 Q6W5P4 1/20 0.51
APAF1 O14727 1/20 0.50
EGLN3 Q9H6Z9 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
FDPS P14324 2/20 0.49
PKM P14618 1/20 0.48
GGPS1 O95749 1/20 0.48
ALOX15 P16050 1/20 0.48
CYP11B1 P15538 3/20 0.47
CYP11B2 P19099 3/20 0.47
TNF P01375 1/20 0.47
MAPT P10636 1/20 0.47
STAT3 P40763 1/20 0.47
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1023745 0.84 TDP1 (0.70) TDP1LMNASMN1; SMN2HTTTSHR
SCHEMBL6174975 0.83 TDP1 (0.68) TDP1LMNASMN1; SMN2HTTTSHR
SCHEMBL10894684 0.81 TDP1 (0.66) TDP1LMNASMN1; SMN2HTTTSHR
SCHEMBL13723111 0.80 TDP1 (0.64) TDP1LMNASMN1; SMN2HTTTSHR
SCHEMBL9181106 0.79 TDP1 (0.62) TDP1LMNASMN1; SMN2HTTTSHR
SCHEMBL9450146 0.79 TDP1 (0.62) TDP1LMNASMN1; SMN2HTTTSHR
SCHEMBL10130604 0.78 TDP1 (0.66) TDP1LMNASMN1; SMN2HTTTSHR
SCHEMBL6442808 0.78 TDP1 (1.00) TDP1LMNASMN1; SMN2HTTTSHR
SCHEMBL13233290 0.78 TDP1 (0.70) TDP1LMNASMN1; SMN2HTTTSHR
SCHEMBL18722520 0.77 TDP1 (0.58) TDP1LMNASMN1; SMN2HTTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080103130-A1 7-hydroxy-6-{[1-methyl-3-(1,3-thiazol-5-yl)propyl]amino}-4,5,6,7-tetrahydroimidazo[4,5,1-jk][1]benzazepin-2(1H)-one; agonists at the beta-2 adrenoceptor; feed additives for livestock animals; improving meat yield or meat quality PFIZER LIMITED (GB) 2008-05-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080103130-A1 7-hydroxy-6-{[1-methyl-3-(1,3-thiazol-5-yl)propyl]amino}-4,5,6,7-tetrahydroimidazo[4,5,1-jk][1]benzazepin-2(1H)-one; agonists at the beta-2 adrenoceptor; feed additives for livestock animals; improving meat yield or meat quality ADRB2, ADRB1, ADRA2C TDP1 2966/4885LMNA 999/4885SMN1; SMN2 1803/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.